Ropivacaine Hydrochloride Injection
Product Images NDC 65145-166

13 FDA label images from Caplin Steriles Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 65145-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ropivacaine-image (Ropivacaine Image)

Ropivacaine-image (Ropivacaine Image)
Chemical structure of ropivacaine hydrochloride, showing its molecular arrangement including a substituted aromatic ring, amide linkage, and piperidine ring with hydrochloride salt.*
FDA Label Image

Image10 (Ropivacaine10)

Image10 (Ropivacaine10)
Ropivacaine Hydrochloride Injection, USP 5 mg/mL (0.5%) in a carton containing 10 single-dose 30 mL vials. The label indicates use for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Caplin Steriles Limited, India, with a note that the container closure is not made with natural rubber latex.*
FDA Label Image

Image11 (Ropivacaine11)

Image11 (Ropivacaine11)
Label for Ropivacaine Hydrochloride Injection, USP 1% (10 mg/mL), 200 mg/20 mL single-dose vial by Caplin Steriles Limited. It is indicated for epidural administration only and contains 10 mg of Ropivacaine HCl per mL. The label includes storage instructions, manufacturer details from India, and a barcode.*
FDA Label Image

Image12 (Ropivacaine12)

Image12 (Ropivacaine12)
Packaging label for Ropivacaine Hydrochloride Injection, USP 1% (10 mg/mL), with a total of 200 mg per 20 mL vial. The label indicates use for epidural administration only and is not for intravenous use. Package contains 10 single-dose 20 mL vials. Manufactured by Caplin Steriles Limited, India, with storage instructions at 20° to 25°C (68° to 77°F).*
FDA Label Image

Image13 (Ropivacaine13)

Image13 (Ropivacaine13)
Ropivacaine Hydrochloride Injection, USP 1% (10 mg/mL) in a 20 mL single-dose vial carton. The label states this is for epidural administration only, not for intravenous use. The package contains 10 x 20 mL single dose vials. The product is sterile, nonpyrogenic, preservative-free, labeled for Rx use, and manufactured by Caplin Steriles Limited.*
FDA Label Image

Image2 (Ropivacaine2)

Image2 (Ropivacaine2)
Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg/mL) in a 20 mL single-dose vial label from Caplin Steriles Limited. The label indicates the 40 mg/20 mL strength, specifies use for infiltration, nerve block, and epidural administration only, and notes it is sterile, nonpyrogenic, preservative-free. Storage instructions and manufacturer details including NDC 65145-107-01 are also visible.*
FDA Label Image

Image3 (Ropivacaine3)

Image3 (Ropivacaine3)
Label for Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg/mL) featuring 40 mg/20 mL strength. The label states it is for infiltration, nerve block, and epidural administration only, not for intravenous use. Packaging contains 10 single-dose vials of 20 mL each. Additional information notes sterile, preservative-free formulation and instructions regarding storage and use. Labeler is Caplin Steriles Limited.*
FDA Label Image

Image4 (Ropivacaine4)

Image4 (Ropivacaine4)
Label for Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg/mL) containing 40 mg per 20 mL vial. The label specifies use for infiltration, nerve block, and epidural administration only, and not for intravenous use. It is packaged as 10 single-dose 20 mL vials and manufactured by Caplin Steriles Limited, India.*
FDA Label Image

Image5 (Ropivacaine5)

Image5 (Ropivacaine5)
Label for Ropivacaine Hydrochloride Injection USP 0.5% (5 mg/mL) in a 20 mL single-dose vial. The label indicates it is for infiltration, nerve block, and epidural administration only, not for intravenous use. It is manufactured by Caplin Steriles Limited, India.*
FDA Label Image

Image6 (Ropivacaine6)

Image6 (Ropivacaine6)
Label for Ropivacaine Hydrochloride Injection USP 0.5% (5 mg/mL), 100 mg/20 mL, supplied in 10 x 20 mL single dose vials. Indicated for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Caplin Steriles Limited, India. Includes storage instructions and barcode.*
FDA Label Image

Image7 (Ropivacaine7)

Image7 (Ropivacaine7)
Ropivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) in 20 mL single dose vials, 10 vials per box. The label specifies use for infiltration, nerve block, and epidural administration only, not for intravenous use. Each mL contains ropivacaine HCl 5 mg with sodium chloride and sodium hydroxide or hydrochloric acid for pH adjustment. Packaged by Caplin Steriles Limited.*
FDA Label Image

Image8 (Ropivacaine8)

Image8 (Ropivacaine8)
Label for Ropivacaine Hydrochloride Injection, USP 5 mg/mL (0.5%) in a 30 mL single dose vial. Indicated for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Caplin Steriles Limited, India. Includes storage instructions, contents per mL, and a barcode.*
FDA Label Image

Image9 (Ropivacaine9)

Image9 (Ropivacaine9)
Packaging label for Ropivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) by Caplin Steriles Limited. The label states a concentration of 150 mg/30 mL and indicates use for infiltration, nerve block, and epidural administration only. It contains 10 single-dose vials of 30 mL each, with instructions and storage information also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.